Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tzong Shin Tzai

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Molecular and Clinical Oncology|September 30, 2024
Clinical relevance of urinary 8‑hydroxydeoxyguanosine levels in patients undergoing prostate biopsyYi-Chia Hsieh, Ian Seng Cheong, Lin-Nei Hsu, et al.
Urology|March 29, 2008
Clinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groupsChung-Hsin Chen, Tzong-Shin Tzai, Shu-Pin Huang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 22, 2013
TGF-β1 conjugated to gold nanoparticles results in protein conformational changes and attenuates the biological functionYuh-Shyan Tsai, Yu-Hung Chen, Pai-Chiao Cheng, et al.
Ecotoxicology and Environmental Safety|January 21, 2025
Phthalate exposure induces microRNA-5010/Nrf2-EGR1/GDF15 signaling expression in prostate cancerYuh-Shyan Tsai, Yeong-Chin Jou, Ian Seng Cheong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulationHong-Lin Cheng, Barry Trink, Tzong-Shin Tzai, et al.
Anticancer Research|February 6, 2009
Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladderJung-Chin Chen, Chung-Liang Ho, Hung-Wen Tsai, et al.
Urology|August 12, 2008
Aberrant prothymosin-alpha expression in human bladder cancerYuh-Shyan Tsai, Yeong-Chin Jou, Gia-Fong Lee, et al.
Proteomics. Clinical Applications|February 16, 2011
Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labelingHong-Lin Cheng, Hung-Jen Huang, Bing-Yuan Ou, et al.
Journal of Biomedical Science|August 27, 2017
The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesisHong-Yi Chang, Hsin-Mei Chang, Tsung-Jung Wu, et al.
Molecular Cancer Therapeutics|January 17, 2016
RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer DrugsHong-Yi Chang, Ting-Chia Chang, Wen-Ya Huang, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Molecular and Clinical Oncology|September 30, 2024
Clinical relevance of urinary 8‑hydroxydeoxyguanosine levels in patients undergoing prostate biopsyYi-Chia Hsieh, Ian Seng Cheong, Lin-Nei Hsu, et al.
Urology|March 29, 2008
Clinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groupsChung-Hsin Chen, Tzong-Shin Tzai, Shu-Pin Huang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 22, 2013
TGF-β1 conjugated to gold nanoparticles results in protein conformational changes and attenuates the biological functionYuh-Shyan Tsai, Yu-Hung Chen, Pai-Chiao Cheng, et al.
Ecotoxicology and Environmental Safety|January 21, 2025
Phthalate exposure induces microRNA-5010/Nrf2-EGR1/GDF15 signaling expression in prostate cancerYuh-Shyan Tsai, Yeong-Chin Jou, Ian Seng Cheong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulationHong-Lin Cheng, Barry Trink, Tzong-Shin Tzai, et al.
Anticancer Research|February 6, 2009
Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladderJung-Chin Chen, Chung-Liang Ho, Hung-Wen Tsai, et al.
Urology|August 12, 2008
Aberrant prothymosin-alpha expression in human bladder cancerYuh-Shyan Tsai, Yeong-Chin Jou, Gia-Fong Lee, et al.
Proteomics. Clinical Applications|February 16, 2011
Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labelingHong-Lin Cheng, Hung-Jen Huang, Bing-Yuan Ou, et al.
Journal of Biomedical Science|August 27, 2017
The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesisHong-Yi Chang, Hsin-Mei Chang, Tsung-Jung Wu, et al.
Molecular Cancer Therapeutics|January 17, 2016
RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer DrugsHong-Yi Chang, Ting-Chia Chang, Wen-Ya Huang, et al.
Pageof 6